Literature DB >> 21524714

Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused?

Jeanne M Marrazzo1.   

Abstract

Bacterial vaginosis (BV) is a common cause of vaginitis and increases women's risk of pelvic inflammatory disease, adverse pregnancy outcomes, and risk of STD/HIV acquisition. The etiology of BV is unclear, though it is believed to involve loss of vaginal hydrogen peroxide-producing lactobacilli and acquisition of complex bacterial communities that include many fastidious BV-associated bacteria (BVAB) that have recently been detected using PCR methods. Treatment failure (persistence) is common, and may be facilitated by unprotected sex. Potential contributions to BV and BV persistence include (1) sexual partners as a reservoir for BVAB; (2) specific sexual practices, including male partners' condom use; and (3) the composition of the vaginal microbiota involved in BV. Specific BVAB in the Clostridiales order may predict BV persistence when detected pre-treatment, and have been detected in men whose female partners have BV. BVAB may be associated with unprotected sexual behavior and failure of BV to resolve in women, supporting the hypothesis that BVAB colonization of male genitalia may serve as a reservoir for re-infection of female partners. Moreover, specific sexual practices may favor vaginal colonization with certain BVAB that have been associated with persistence. This review provides background on BV, and discusses the epidemiologic and microbiologic data to support a role for acquisition of BVAB and how this process might differ among subsets of women.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21524714      PMCID: PMC3155735          DOI: 10.1016/j.anaerobe.2011.03.016

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  41 in total

1.  Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.

Authors:  Sixto Sanchez; Patricia J Garcia; Katherine K Thomas; Mary Catlin; King K Holmes
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

2.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

3.  Exposure to chronic stress and ethnic differences in rates of bacterial vaginosis among pregnant women.

Authors:  Jennifer F Culhane; Virginia Rauh; Kelly Farley McCollum; Irma T Elo; Vijaya Hogan
Journal:  Am J Obstet Gynecol       Date:  2002-11       Impact factor: 8.661

4.  Risk factors for cervicitis among women with bacterial vaginosis.

Authors:  Jeanne M Marrazzo; Harold C Wiesenfeld; Pamela J Murray; Barbara Busse; Leslie Meyn; Marijane Krohn; Sharon L Hillier
Journal:  J Infect Dis       Date:  2006-02-02       Impact factor: 5.226

5.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Daniel V Landers; Richard L Sweet
Journal:  Clin Infect Dis       Date:  2003-02-07       Impact factor: 9.079

7.  Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.

Authors:  Jeanne M Marrazzo; David H Martin; D Heather Watts; Joann Schulte; Jack D Sobel; Sharon L Hillier; Carolyn Deal; David N Fredricks
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

8.  Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy.

Authors:  C A Spiegel; D A Eschenbach; R Amsel; K K Holmes
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

Review 9.  Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient.

Authors:  R L Sweet
Journal:  Infect Dis Obstet Gynecol       Date:  2000

10.  The effects of circumcision on the penis microbiome.

Authors:  Lance B Price; Cindy M Liu; Kristine E Johnson; Maliha Aziz; Matthew K Lau; Jolene Bowers; Jacques Ravel; Paul S Keim; David Serwadda; Maria J Wawer; Ronald H Gray
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more
  43 in total

Review 1.  The human urinary microbiome and how it relates to urogynecology.

Authors:  Jenifer Schneeweiss; Marianne Koch; Wolfgang Umek
Journal:  Int Urogynecol J       Date:  2016-01-25       Impact factor: 2.894

2.  Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.

Authors:  Kristen R Moore; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Jennifer S Smith; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2015-04-22       Impact factor: 2.681

Review 3.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

Review 4.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

5.  Associations between vaginal bacteria implicated in HIV acquisition risk and proinflammatory cytokines and chemokines.

Authors:  Michelle C Sabo; Dara A Lehman; Bingjie Wang; Barbra A Richardson; Sujatha Srinivasan; Lusi Osborn; Daniel Matemo; John Kinuthia; Tina L Fiedler; Matthew M Munch; Alison L Drake; David N Fredricks; Julie Overbaugh; Grace John-Stewart; R Scott McClelland; Susan M Graham
Journal:  Sex Transm Infect       Date:  2019-06-13       Impact factor: 3.519

6.  Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.

Authors:  B D Modena; R Milam; F Harrison; J A Cheeseman; M M Abecassis; J J Friedewald; A D Kirk; D R Salomon
Journal:  Am J Transplant       Date:  2016-10-11       Impact factor: 8.086

7.  Temporal dynamics of the human vaginal microbiota.

Authors:  Pawel Gajer; Rebecca M Brotman; Guoyun Bai; Joyce Sakamoto; Ursel M E Schütte; Xue Zhong; Sara S K Koenig; Li Fu; Zhanshan Sam Ma; Xia Zhou; Zaid Abdo; Larry J Forney; Jacques Ravel
Journal:  Sci Transl Med       Date:  2012-05-02       Impact factor: 17.956

8.  Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women.

Authors:  Paria Mirmonsef; Sharada Modur; Derick Burgad; Douglas Gilbert; Elizabeth T Golub; Audrey L French; Kerrie McCotter; Alan L Landay; Greg T Spear
Journal:  Menopause       Date:  2015-07       Impact factor: 2.953

Review 9.  Antibiotic treatment for the sexual partners of women with bacterial vaginosis.

Authors:  Jairo Amaya-Guio; David Andres Viveros-Carreño; Eloisa Mercedes Sierra-Barrios; Mercy Yolima Martinez-Velasquez; Carlos F Grillo-Ardila
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

10.  Bacteriophages of the Urinary Microbiome.

Authors:  Taylor Miller-Ensminger; Andrea Garretto; Jonathon Brenner; Krystal Thomas-White; Adriano Zambom; Alan J Wolfe; Catherine Putonti
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.